Lack of intensive treatment of CHD risk factors: Could the physician be the most important risk factor?

被引：0

作者：

Vogel, RA

机构：

来源：

AMERICAN JOURNAL OF MANAGED CARE | 1997年 / 3卷

关键词：

D O I：

暂无

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

Interventions that reduce the risk of CHD are widely underused by physicians. Data overwhelmingly support the use of statins to lower total cholesterol and LDL-C levels, yet less than 25% of patients with coronary heart disease in the United States are treated with lipid-lowering drugs. Perhaps the physician is the most important risk factor for underuse of cholesterol-lowering strategies. Effective programs that are nurse-based can improve delivery of risk factor management in patients hospitalized for CHD. A model program has been implemented at the University of Maryland.

引用

收藏

页码：S40 / S43

页数：4

相关论文

共 10 条

[1] Cost-effectiveness of Pravastatin in secondary prevention of coronary artery disease [J].

Ashraf, T ;

Hay, JW ;

Pitt, B ;

Wittels, E ;

Crouse, J ;

Davidson, M ;

Furberg, CD ;

Radican, L .

AMERICAN JOURNAL OF CARDIOLOGY, 1996, 78 (04) :409-414

[2]

AVANIAN JZ, 1994, NEW ENGL J MED, V331, P1136

[3] LOW RATE OF TREATMENT OF HYPERCHOLESTEROLEMIA BY CARDIOLOGISTS IN PATIENTS WITH SUSPECTED AND PROVEN CORONARY-ARTERY DISEASE [J].

COHEN, MV ;

BYRNE, MJ ;

LEVINE, B ;

GUTOWSKI, T ;

ADELSON, R .

CIRCULATION, 1991, 83 (04) :1294-1304

[4] QUALITY OF CARE FOR MEDICARE PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION - A 4-STATE PILOT-STUDY FROM THE COOPERATIVE CARDIOVASCULAR PROJECT [J].

ELLERBECK, EF ;

JENCKS, SF ;

RADFORD, MJ ;

KRESOWIK, TF ;

CRAIG, AS ;

GOLD, JA ;

KRUMHOLZ, HM ;

VOGEL, RA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 273 (19) :1509-1514

[5] POPULATION AWARENESS AND CONTROL OF HYPERTENSION AND HYPERCHOLESTEROLEMIA - THE ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY [J].

NIETO, FJ ;

ALONSO, J ;

CHAMBLESS, LE ;

ZHONG, M ;

CERASO, M ;

ROMM, FJ ;

COOPER, L ;

FOLSOM, AR ;

SZKLO, M .

ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (07) :677-684

[6]

PEDERSEN TR, 1994, LANCET, V344, P1383

[7] The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels [J].

Sacks, FM ;

Pfeffer, MA ;

Moye, LA ;

Rouleau, JL ;

Rutherford, JD ;

Cole, TG ;

Brown, L ;

Warnica, JW ;

Arnold, JMO ;

Wun, CC ;

Davis, BR ;

Braunwald, E .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) :1001-1009

[8] PREVENTION OF CORONARY HEART-DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA [J].

SHEPHERD, J ;

COBBE, SM ;

FORD, I ;

ISLES, CG ;

LORIMER, AR ;

MACFARLANE, PW ;

MCKILLOP, JH ;

PACKARD, CJ .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (20) :1301-1307

[9]

VOGEL RA, IN PRESS AM J CARDIO

[10]

VOGEL RA, 1994, LIPID REV, V1, P1